跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 24 条关于
“Nxera”
全部
24
临床试验
5
药物
0
机构
1
资讯
18
去年
Nxera Pharma Launches Comprehensive Obesity Pipeline with Novel Oral GLP-1 Agonist
7个月前
Nxera Pharma Licenses GPCR-Targeted Program to Investment Firm-Backed Spin-Out Company
去年
Centessa Pharmaceuticals Initiates Phase 2 Trial of ORX750 for Sleep-Wake Disorders
去年
Nxera Pharma Achieves Key Development Milestone in Eli Lilly Collaboration for Diabetes and Metabolic Disease Treatments
10个月前
Nxera Pharma Announces Strategic Restructuring with 15% Workforce Reduction to Focus on GPCR Pipeline
2年前
Nxera Pharma Secures $35M Milestone Payment After Positive Phase II Schizophrenia Trial
9个月前
Nxera Pharma Regains Rights to Phase 2-Ready Schizophrenia Drug After Boehringer Ingelheim Declines Licensing Option
去年
Nxera Pharma Initiates Phase 3 Trial of Daridorexant for Insomnia in South Korea
去年
Nxera Pharma Partners with Holling Bio-Pharma to Launch Daridorexant for Insomnia in Taiwan
去年
Viatris Acquires Global Rights to Cenerimod for Autoimmune Diseases with $10M Nxera Deal
第 1 页,共 2 页
上一页
下一页